March 06, 2015 8:22 AM ET

Biotechnology

Company Overview of Chelsea Therapeutics International Ltd.

Executive Profile

William D. Schwieterman M.D.

Advisor, Avidia, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
56--

Background

Dr. William D. Schwieterman, also known as Bill, M.D., is the Founder of Tekgenics Inc., and serves as its President. Dr. Schwieterman has been the Chief Medical Officer at Chelsea Therapeutics International since November 2009 and serves as its Vice President. He serves as an Advisor at Avidia, Inc., and has been an Independent Consultant for biotech and pharmaceutical companies since July 2002. He is a veteran of the National Institutes of Health. He is an expert in ...

Corporate Headquarters

3530 Toringdon Way
Charlotte, North Carolina 28277

United States

Phone: 704-341-1516
Fax: --

Board Members Memberships

2007-Present
Director and Chairman of Nominating & Governance Committee
2008-2009
Chief Medical Officer and Vice President

Education

BS
University of Cincinnati
MD
University of Cincinnati

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chelsea Therapeutics International Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.